Heartburn & Esophageal Disorders Center

About this Clinic

Taking a comprehensive/multidisciplinary approach to treating GERD, achalasia, Barrett’s Esophagus, complex hiatal hernias, and other esophageal disorders.

The Center for Heartburn & Esophageal Disorders at UT Health Austin focuses on the diagnosis and treatment for disorders of the foregut, which refers to the esophagus and stomach. Gastroesophageal reflux disease is the most common condition of the foregut, affecting millions of Americans of all ages. Patients may feel limited by their current medication or treatment options, which may often treat the symptoms, but not the disease. In time, acid reflux symptoms may worsen, affecting an individual’s eating, sleeping, and overall health. However, there are options to you.

Our Digestive Health and Surgery Center care team will work with you to diagnose and treat the cause of your acid reflux. In some cases, surgical treatments may relieve acid reflux for good! Our team also diagnoses and treats other conditions of the esophagus, including laryngopharyngeal reflux (LPR), achalasia, Barrett’s Esophagus, complex hiatal hernias, failed fundoplications (redo-operations), and other espophageal disorders.

Treatment Options

Our Center offers several treatment options for heartburn and acid reflux. When you meet with our care team, we will create a personalized care plan to help alleviate your symptoms. Treatment options may include:

  • Lifestyle modifications
  • Medications
  • Endoscopic Treatment
  • Surgery

LINX® Reflux Management

As the only available FDA-approved device to treat GERD at the source, the LINX® Reflux Management System is an option for those whose reflux is not managed, even with medications.

Dr. Buckley is one of the leading implanters of LINX® in the country and has published several research papers on the procedure, including new applications for larger hiatal hernias

EndoStim FDA Trial

We are currently enrolling patients in an international multi-center trial for this innovative procedure to treat GERD.

The trial is called the LESS GERD trial. The trial is a multicenter, randomized, double-blind, sham-controlled pivotal trial designed to evaluate the safety and efficacy of the EndoStim Lower Esophageal Sphincter (LES) Stimulation System in patients with gastro-esophageal reflux disease (GERD) who experience symptoms despite taking high-dose proton pump inhibitor (PPI) medications. Dr. Buckley is the local Principle Investigator.

EndoStim’s LES Stimulation System is a minimally-invasive implantable device designed to provide long-term reflux control by restoring normal esophageal function through neurostimulation. The therapy directly targets the patient’s weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and the esophagus, often the underlying cause of reflux.

To see if you may qualify for this study visit http://www.lessgerd.com/ or call 512-324-GERD (4373).


We are actively involved in measuring our outcomes and publishing our research to continue to lead the field in foregut and esophageal surgery. This research not only benefits the individual patient participating in the research, but contributes to finding more advanced, efficient treatments for future patients.